AbCellera Biologics Inc. Quarterly Current Ratio in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
AbCellera Biologics Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q2 2024.
  • AbCellera Biologics Inc. Current Ratio for the quarter ending June 30, 2024 was 835 %, a 8.34% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 835 -76 -8.34% Jun 30, 2024
Q1 2024 781 +3.92 +0.51% Mar 31, 2024
Q4 2023 837 +171 +25.6% Dec 31, 2023
Q3 2023 873 +224 +34.5% Sep 30, 2023
Q2 2023 911 +241 +35.9% Jun 30, 2023
Q1 2023 777 -55.3 -6.65% Mar 31, 2023
Q4 2022 666 -401 -37.6% Dec 31, 2022
Q3 2022 649 -440 -40.4% Sep 30, 2022
Q2 2022 670 Jun 30, 2022
Q1 2022 832 Mar 31, 2022
Q4 2021 1.07K Dec 31, 2021
Q3 2021 1.09K Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.